|
1
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beitzinger M and Meister G: Preview.
MicroRNAs: From decay to decoy. Cell. 140:612–614. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gebert LFR and MacRae IJ: Regulation of
microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ortiz-Quintero B: Cell-free microRNAs in
blood and other body fluids, as cancer biomarkers. Cell Prolif.
49:281–303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gambari R, Brognara E, Spandidos DA and
Fabbri E: Targeting oncomiRNAs and mimicking tumor suppressor
miRNAs: New trends in the development of miRNA therapeutic
strategies in oncology. Int J Oncol. 49:5–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slotwinski R, Lech G and Slotwinska SM:
MicroRNAs in pancreatic cancer diagnosis and therapy. Cent Eur J
Immunol. 43:314–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen D, Wu X, Xia M, Wu F, Ding J, Jiao Y,
Zhan Q and An F: Upregulated exosomic miR23b-3p plays regulatory
roles in the progression of pancreatic cancer. Oncol Rep.
38:2182–2188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Y, Yang L and Li Y: Neuropilin-1
(NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion
in pancreatic neuroendocrine neoplasms. Hum Pathol. 81:192–200.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song M, Bode AM, Dong Z and Lee MH: AKT as
a therapeutic target for cancer. Cancer Res. 79:1019–1031. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou Y, Fu X, Guan Y, Gong M, He K and
Huang B: 1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses
human breast cancer cell proliferation and metastasis through
IL6/JAK2/PI3K pathway. Biochem Pharmacol. 172:1137522020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan K, Yang C, Fan Z, Huang Q, Zhang Y,
Cheng H, Jin K, Lu Y, Wang Z, Luo G, et al: MUC16 C
terminal-induced secretion of tumor-derived IL-6 contributes to
tumor-associated Treg enrichment in pancreatic cancer. Cancer Lett.
418:167–175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haddadi N, Lin Y, Travis G, Simpson AM,
Nassif NT and McGowan EM: PTEN/PTENP1: Regulating the regulator of
RTK-dependent PI3K/Akt signalling, new targets for cancer therapy.
Mol Cancer. 17:372018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu W, Yang Z, Xie C, Zhu Y, Shu X, Zhang
Z, Li N, Chai N, Zhang S, Wu K, et al: PTEN lipid phosphatase
inactivation links the hippo and PI3K/Akt pathways to induce
gastric tumorigenesis. J Exp Clin Cancer Res. 37:1982018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki A, de la Pompa JL, Stambolic V,
Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A,
Khoo W, et al: High cancer susceptibility and embryonic lethality
associated with mutation of the PTEN tumor suppressor gene in mice.
Curr Biol. 8:1169–1178. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Cristofano A, Pesce B, Cordon-Cardo C
and Pandolfi PP: Pten is essential for embryonic development and
tumour suppression. Nat Genet. 19:348–355. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luongo F, Colonna F, Calapà F, Vitale S,
Fiori ME and De Maria R: PTEN Tumor-Suppressor: The dam of stemness
in cancer. Cancers (Basel). 11:10762019. View Article : Google Scholar
|
|
19
|
Li G, Robinson GW, Lesche R, Martinez-Diaz
H, Jiang Z, Rozengurt N, Wagner KU, Wu DC, Lane TF, Liu X, et al:
Conditional loss of PTEN leads to precocious development and
neoplasia in the mammary gland. Development. 129:4159–4170.
2002.PubMed/NCBI
|
|
20
|
Jiang N, Dai Q, Su X, Fu J, Feng X and
Peng J: Role of PI3K/AKT pathway in cancer: The framework of
malignant behavior. Mol Biol Rep. 47:4587–4629. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ebrahimi S, Hosseini M, Shahidsales S,
Maftouh M, Ferns GA, Ghayour-Mobarhan M, Hassanian SM and Avan A:
Targeting the Akt/PI3K signaling pathway as a potential therapeutic
strategy for the treatment of pancreatic cancer. Curr Med Chem.
24:1321–1331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wolin EM: PI3K/Akt/mTOR pathway inhibitors
in the therapy of pancreatic neuroendocrine tumors. Cancer Lett.
335:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xueli B, Tao M and Ting-Bo L:
Interpretation of NCCN clinical practice guidelines in oncology:
Pancreatic adenocarcinoma (version 1, 2016). Chin J Pract Surg.
36:870–871. 2016.
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
An F, Yamanaka S, Allen S, Roberts LR,
Gores GJ, Pawlik TM, Xie Q, Ishida M, Mezey E, Ferguson-Smith AC,
et al: Silencing of miR-370 in human cholangiocarcinoma by allelic
loss and interleukin-6 induced maternal to paternal epigenotype
switch. PLoS One. 7:e456062012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Poling BC, Tsai K, Kang D, Ren L, Kennedy
EM and Cullen BR: A lentiviral vector bearing a reverse intron
demonstrates superior expression of both proteins and microRNAs.
RNA Biol1. 4:1570–1579. 2017. View Article : Google Scholar
|
|
27
|
Song C, Han Y, Luo H, Qin Z, Chen Z, Liu
Y, Lu S, Sun H and Zhou C: HOXA10 induces BCL2 expression, inhibits
apoptosis, and promotes cell proliferation in gastric cancer.
Cancer Med. 8:5651–5661. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Conway JR, Herrmann D, Evans TJ, Morton JP
and Timpson P: Combating pancreatic cancer with PI3K pathway
inhibitors in the era of personalised medicine. Gut. 68:742–758.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Wu H, Li W, Yin L, Guo S, Xu X,
Ouyang Y, Zhao Z, Liu S, Tian Y, et al: Downregulated miR-506
expression facilitates pancreatic cancer progression and
chemoresistance via SPHK1/Akt/NF-κB signaling. Oncogene.
35:5501–5514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ying H, Dey P, Yao W, Kimmelman AC,
Draetta GF, Maitra A and DePinho RA: Genetics and biology of
pancreatic ductal adenocarcinoma. Genes Dev. 30:355–385. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao Z, Luo G, Liu C, Wu C, Liu L, Liu Z,
Ni Q, Long J and Yu X: Molecular mechanism underlying lymphatic
metastasis in pancreatic cancer. Biomed Res Int. 2014:9258452014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang X, Shi G, Gao F, Liu P, Wang H and
Tan X: TSPAN1 upregulates MMP2 to promote pancreatic cancer cell
migration and invasion via PLCγ. Oncol Rep. 41:2117–2125.
2019.PubMed/NCBI
|
|
33
|
Grossi I, Salvi A, Baiocchi G, Portolani N
and De Petro G: Functional role of microRNA-23b-3p in cancer
biology. Microrna. 7:156–166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Li J, Lai XN, Jiao XQ, Xiong JP
and Xiong LX: Focus on Cdc42 in breast cancer: New insights, target
therapy development and non-coding RNAs. Cells. 8:462019.
View Article : Google Scholar
|
|
35
|
Weidle UH, Birzele F and Nopora A:
Pancreatic ductal adenocarcinoma: MicroRNAs affecting tumor growth
and metastasis in preclinical in vivo models. Cancer Genomics
Proteomics. 16:451–464. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Daoud AZ, Mulholland EJ, Cole G and
McCarthy HO: MicroRNAs in pancreatic Cancer: Biomarkers,
prognostic, and therapeutic modulators. BMC Cancer. 19:11302019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lv Y and Huang S: Role of non-coding RNA
in pancreatic cancer. Oncol Lett. 18:3963–3973. 2019.PubMed/NCBI
|
|
38
|
Shams R, Saberi S, Zali M, Sadeghi A,
Ghafouri-Fard S and Aghdaei HA: Identification of potential
microRNA panels for pancreatic cancer diagnosis using microarray
datasets and bioinformatics methods. Sci Rep. 10:75592020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
An N and Zheng B: miR-203a-3p inhibits
pancreatic cancer cell proliferation, EMT, and apoptosis by
regulating SLUG. Technol Cancer Res Treat. 19:15330338198987292020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Begum S, Hayashi M, Ogawa T, Jabboure FJ,
Brait M, Izumchenko E, Tabak S, Ahrendt SA, Westra WH, Koch W, et
al: An integrated genome-wide approach to discover deregulated
microRNAs in non-small cell lung cancer: Clinical significance of
miR-23b-3p deregulation. Sci Rep. 5:132362015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lei Y and Li JT: Affinity of
penicillin-binding proteins of Escherichia coli K-12 for
furbenicillin and other beta-lactam antibiotics. Zhongguo Yao Li
Xue Bao. 10:177–180. 1989.(In Chinese). PubMed/NCBI
|
|
42
|
Hu X, Wang Y, Liang H, Fan Q, Zhu R, Cui
J, Zhang W, Zen K, Zhang CY, Hou D, et al: miR-23a/b promote tumor
growth and suppress apoptosis by targeting PDCD4 in gastric cancer.
Cell Death Dis. 8:e30592017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu C, Zhao Y, Liu Y, Yang X, Yan M, Min Y,
Pan Z, Qiu S, Xia S, Yu J, et al: Identifying miRNA-mRNA regulation
network of major depressive disorder in ovarian cancer patients.
Oncol Lett. 16:5375–5382. 2018.PubMed/NCBI
|
|
44
|
Xu X, Yu Y, Zong K, Lv P and Gu Y:
Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic
cancer promotes cancer proliferation by activating the PI3K/Akt
signaling pathway. J Exp Clin Cancer Res. 38:4972019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Falasca M, Selvaggi F, Buus R, Sulpizio S
and Edling CE: Targeting phosphoinositide 3-kinase pathways in
pancreatic cancer-from molecular signalling to clinical trials.
Anticancer Agents Med Chem. 11:455–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Slattery ML, Mullany LE, Sakoda LC, Wolff
RK, Stevens JR, Samowitz WS and Herrick JS: The PI3K/AKT signaling
pathway: Associations of miRNAs with dysregulated gene expression
in colorectal cancer. Mol Carcinog. 57:243–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kong L, Liu P, Zheng M, Wang Z, Gao Y,
Liang K, Wang H and Tan X: The miR-1224-5p/ELF3 Axis regulates
malignant behaviors of pancreatic cancer via PI3K/AKT/Notch
signaling pathways. Onco Targets Ther. 13:3449–3466. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pop VV, Seicean A, Lupan I, Samasca G and
Burz CC: IL-6 roles-molecular pathway and clinical implication in
pancreatic cancer-A systemic review. Immunol Lett. 181:45–50. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang M, Wu X, Cao H, Zhan Q, Xia M, Zhou
Q, Cai X and An F: Regulatory role of serum miR-224 in invasiveness
and metastasis of cholangiocarcinoma. Zhonghua Gan Zang Bing Za
Zhi. 23:748–753. 2015.(In Chinese). PubMed/NCBI
|
|
50
|
Chen X, Lai Y, Song X, Wu J, Wang L, Zhang
H, Liu Z and Wang Y: Polysaccharides from Citrus grandis
associate with luteolin relieves chronic pharyngitis by
anti-inflammatory via suppressing NF-κB pathway and the
polarization of M1 macrophages. Int J Immunopathol Pharmacol.
32:20587384187805932018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Milella M, Falcone I, Conciatori F, Cesta
Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S,
Cognetti F and Ciuffreda L: PTEN: Multiple functions in human
malignant tumors. Front Oncol. 5:242015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zaman MS, Thamminana S, Shahryari V,
Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora
S, et al: Inhibition of PTEN gene expression by oncogenic
miR-23b-3p in renal cancer. PLoS One. 7:e502032012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xiong J, Wang D, Wei A, Lu H, Tan C, Li A,
Tang J, Wang Y, He S, Liu X and Hu W: Deregulated expression of
miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt
signaling via caveolin-1 and PTEN. Exp Cell Res. 361:316–323. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li Y, Song T, Chen Z, Wang Y, Zhang J and
Wang X: Pancreatic stellate cells activation and matrix
metallopeptidase 2 expression correlate with lymph node metastasis
in pancreatic carcinoma. Am J Med Sci. 357:16–22. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhu Y, Yan L, Zhu W, Song X, Yang G and
Wang S: MMP2/3 promote the growth and migration of laryngeal
squamous cell carcinoma via PI3K/Akt-NF-kB-mediated
epithelial-mesenchymal transformation. J Cell Physiol. Feb
4–2019.(Epub ahead of print). doi: 10.1002/jcp.28242.
|
